NCT04874519
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, FLC, +7 more
- Locations
-
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States
Clinical trial condition
Fibrolamellar hepatocellular carcinoma
Explore clinical trials studying Fibrolamellar hepatocellular carcinoma. Study availability and eligibility vary by location and protocol.
16 public trials
9 recruiting studies
Fibrolamellar hepatocellular carcinoma trial results
NCT02159989
- Conditions
- Adenoma, Adenoma, Islet Cell, Adnexal Diseases, +33 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01642186
- Conditions
- Fibrolamellar Carcinoma, Fibrolamellar Liver Cancer, Fibrolamellar hepatocellular carcinoma
- Locations
-
- University of California San Francisco San Francisco, California, United States
- John Hopkins Medical Center Baltimore, Maryland, United States
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
Active, Not Recruiting
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
NCT03533582
- Conditions
- Childhood Hepatocellular Carcinoma, Childhood Malignant Liver Neoplasm, Fibrolamellar Carcinoma, +6 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
Active, Not Recruiting
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer
NCT03860272
- Conditions
- Adnexal Diseases, Advanced Cancer, Angiosarcoma, +42 more
- Locations
-
- HonorHealth Research Institute Scottsdale, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- The Angeles Clinic & Research Institute, a Cedars-Sinai Affiliate Los Angeles, California, United States
- University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
Active, Not Recruiting
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
NCT06521567
- Conditions
- Adenocarcinoma, Astrocytoma, Brain Diseases, +56 more
- Locations
-
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Iowa City, Iowa, United States
- GSK Investigational Site Hackensack, New Jersey, United States
- GSK Investigational Site Cincinnati, Ohio, United States